Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3086  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

DRUG REVIEW

Tigecycline

Bhattacharya M, Parakh A, Narang M

Year : 2009| Volume: 55| Issue : 1 | Page no: 65-68

   This article has been cited by
 
1 Rapid turbidimetric assay to potency evaluation of tigecycline in lyophilized powder
Lucélia Magalhães da Silva,Hérida Regina Nunes Salgado
Journal of Microbiological Methods. 2015; 110: 49
[Pubmed]  [Google Scholar] [DOI]
2 New Therapy Option for Treatment of Methicillin-ResistantStaphylococcus aureusKeratitis: Tigecycline
Sertan Goktas,Muhammet Guzel Kurtoglu,Yasar Sakarya,Ceyhan Ugurluoglu,Muammer Ozcimen,Rabia Sakarya,Ismail Alpfidan,Ismail Senol Ivacik,Erkan Erdogan,Abdulkadir Bukus
Journal of Ocular Pharmacology and Therapeutics. 2015; 31(2): 122
[Pubmed]  [Google Scholar] [DOI]
3 Validation of a stability-indicating RP-LC method for the determination of tigecycline in lyophilized powder
Da Silva, L.M., Salgado, H.R.N.
Journal of Chromatographic Science . 2013; 51(2): 192-199
[Pubmed]  [Google Scholar]
4 Validation of a Stability-Indicating RP-LC Method for the Determination of Tigecycline in Lyophilized Powder
L. M. da Silva,H. R. N. Salgado
Journal of Chromatographic Science. 2013; 51(2): 192
[Pubmed]  [Google Scholar] [DOI]
5 Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections
Y.-T. Lee,S.-M. Tsao,P.-R. Hsueh
European Journal of Clinical Microbiology & Infectious Diseases. 2013; 32(9): 1211
[Pubmed]  [Google Scholar] [DOI]
6 An update for community-acquired bacterial pneumonia pharmacotherapy: Whatæs new and where does it fit?
Debellis, H.F., Jones, M.C., Kincaid, S.E.
Journal of Pharmacy Practice. 2012; 25(6): 569-575
[Pubmed]  [Google Scholar]
7 In vitro activity of tigecycline against multidrug-resistant Gram-negative blood culture isolates from critically ill patients
S. Gupta, C. Aruna, S. Nagaraj, M. Dias, S. Muralidharan
Journal of Antimicrobial Chemotherapy. 2012;
[HTML Full text]  [Google Scholar] [DOI]
8 Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage
Li-Yuan Chen, Tun-Chieh Chen, Yen-Hsu Chen, Chun-Yu Lin, Wei-Ru Lin, Po-Liang Lu
Journal of Microbiology Immunology and Infection. 2011; 44(5): 352
[HTML Full text]  [Google Scholar] [DOI]
9 Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Efthimia Tasina, Anna-Bettina Haidich, Stamatia Kokkali, Malamatenia Arvanitidou
The Lancet Infectious Diseases. 2011;
[HTML Full text]  [Google Scholar] [DOI]
10 Confronting multidrug-resistant Acinetobacter baumannii: a review
Ioannis K. Neonakis,Demetrios A. Spandidos,Efthimia Petinaki
International Journal of Antimicrobial Agents. 2011; 37(2): 102
[Pubmed]  [Google Scholar] [DOI]
11 Ceftobiprole: The First Broad-Spectrum Anti–methicillin-resistant Staphylococcus aureus Beta-Lactam
Elias B. Chahine,Adwoa O. Nornoo
Journal of Experimental & Clinical Medicine. 2011; 3(1): 9
[Pubmed]  [Google Scholar] [DOI]
12 Confronting multidrug-resistant Acinetobacter baumannii: A review
Neonakis, I.K., Spandidos, D.A., Petinaki, E.
International Journal of Antimicrobial Agents. 2011; 37(2): 102-109
[Pubmed]  [Google Scholar]
13 Ceftobiprole: The First Broad-Spectrum Anti-methicillin-resistant Staphylococcus aureus Beta-Lactam
Chahine, E.B., Nornoo, A.O.
Journal of Experimental and Clinical Medicine. 2011; 3(1): 9-16
[Pubmed]  [Google Scholar]
14 Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease
Cai, Y., Wang, R., Liang, B., Bai, N., Liu, Y.
Antimicrobial Agents and Chemotherapy. 2011; 55(3): 1162-1172
[Pubmed]  [Google Scholar]
15 Bacterial contamination of platelets and septic transfusions: Review of the literature and discussion on recent patents about biofilm treatment
Savini, V., Catavitello, C., Astolfi, D., Balbinot, A., Masciarelli, G., Pompilio, A., Quaglietta, A.M., (...), Iacone, A.
Recent Patents on Anti-Infective Drug Discovery. 2010; 5(2): 168-176
[Pubmed]  [Google Scholar]
16 Glycylcyclines - What should pharmacists know about this new class of antimicrobial?
Van Schoor, J.
SA Pharmaceutical Journal. 2010; 77(2): 27-30
[Pubmed]  [Google Scholar]
17 A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice
Dryden, M., Andrasevic, A.T., Bassetti, M., Bouza, E., Chastre, J., Cornaglia, G., Esposito, S., Voss, A.
Clinical Microbiology and Infection. 2010; 16((SUPPL 1)): 3-30
[Pubmed]  [Google Scholar] [DOI]
18 Tigecycline: A Review of Properties, Applications, and Analytical Methods :
Lucélia Magalhães da Silva, Hérida Regina Nunes Salgado
Therapeutic Drug Monitoring. 2010; 32(3): 282-288
[Pubmed]  [Google Scholar] [DOI]
19 Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections?
Stan Deresinski
International Journal of Antimicrobial Agents. 2009; 34: S43
[HTML Full text]  [Google Scholar] [DOI]
20 Prospects for the next anti-Pseudomonas drug
Page, M.G., Heim, J.
Current Opinion in Pharmacology. 2009; 9(5): 558-565
[Pubmed]  [Google Scholar]
21 Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
Midtvedt, T.
Side Effects of Drugs Annual. 2009; 31: 413-425
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow